Drug Database
Back to search

Netherlands· NL-bc59a712bbcc

Moxamar 0,4 mg, filmomhulde tabletten

A moxonidine product containing moxonidine, registered in Netherlands by Teva Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC C02AC05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMoxamar 0,4 mg, filmomhulde tablettenATCC02AC05REGISTER NO.NL-bc59a712bbccPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about moxonidineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Moxonidine is registered in 13 of 19 countries.

Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search moxonidine products by name

Moxonidine · ATC C02AC05

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxonidine costs, country by country.

Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Moxonidine · price per daily dose (0.3 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.70
  • IT Italy$0.35
  • FR France$0.19
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
MOXONIDINE
Manufacturer
Teva Pharma B.V.
Country
Netherlands (NL)
ATC code
C02AC05
ATC class
Moxonidine
Defined daily dose
0.3 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    29254

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Moxonidine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxonidine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Moxonibene, Moxonidin Stada
  • Belgium · Moxonidine Eg, Moxonidine Sandoz
  • Bulgaria · Moxotens, Moксотенс
  • Cyprus · Physiotens, Tarwoxin
  • Czechia · Cynt, Moxonidin Actavis
  • Germany · Moxogamma, Moxonidin 1 A Pharma
  • Denmark · Moxonat, Moxonidin Teva
  • Estonia · Moxogamma, Moxonidin Actavis
  • Spain · Moxon
  • Finland · Moxonidin Ratiopharm, Moxonidin Stada
  • France · Moxonidine Biogaran, Moxonidine Eg
  • United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
  • Greece · Cynt, Fisiotens
  • Croatia · Cynt, Moksonidin Belupo
  • Hungary · Moxogamma, Moxonidin Ratiopharm
  • Italy · Fisiotens, Moxonidina Eg
  • Lithuania · Moxogamma, Moxonidin Hexal
  • Luxembourg · Moxonidine Eg, Moxonidine Viatris
  • Latvia · Moxogamma, Moxonidin Actavis
  • Malta · Physiotens
  • Norway · Moxonidin Actavis, Physiotens
  • Poland · Physiotens
  • Portugal · Moxon
  • Romania · Physiotens
  • Sweden · Moxonidin Actavis, Moxonidin Stada
  • Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
  • Slovakia · Moxogamma, Moxonidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ba5efb44-5878-4529-b9bf-149dd98c6dc4
GET /v1/drugs/ba5efb44-5878-4529-b9bf-149dd98c6dc4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h29254_smpc_en.pdf",
  "strength": null,
  "atc_label": "Moxonidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg29254",
  "excipients": [
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 25 (E 1201)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "MOXONIDINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h29254_piluk.pdf",
  "authorised_at": "2003/03/24",
  "procedure_number": "NL/H/0405/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "29254",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about moxonidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console